The Report on UK Jobs is unique in providing the most comprehensive guide to the UK jobs market, drawing on original survey data provided by recruitment consultancies and employers to provide the first indication each month of labour market trends. The main findings for November are: Growth of permanent placements eases to 18-month low… The number of people placed […]
The Report on UK Jobs is unique in providing the most comprehensive guide to the UK jobs market, drawing on original survey data provided by recruitment consultancies and employers to provide the first indication each month of labour market trends. The main findings for UK jobs in October are: Growth of staff appointments eases… […]
Jena (Germany)/New Delhi (India), November 6, 2014 — Analytik Jena AG has established its own subsidiary in India, AJ Instruments India Pvt. Ltd., in order to strengthen its presence in the Indian market. The subsidiary is based in New Delhi, from where the Company will serve the customers of its largest business unit, Analytical […]
“Our strong fourth quarter and fiscal year 2014 results mark the conclusion of another successful year for the Company,” said Vincent A. Forlenza, Chairman, CEO and President. “Organic revenue growth continued to accelerate and we delivered a higher quality of earnings while maintaining our ongoing investments to support our innovation strategy. We have built […]
FEI Company (Nasdaq:FEIC) reported results for third quarter of 2014. Revenue of $227.8 million was up 4.2% compared to $218.5 million in the third quarter of 2013 and down 3.9% compared to $237.0 million in the second quarter of 2014. Net bookings in the third quarter were $250.1 million with a book-to-bill ratio of […]
Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third quarter 2014 revenue included the achievement of the $10.0 million milestone related to Roche along with the $1.7 million quarterly amortization from the upfront Roche payment in addition to […]
“We’re pleased to extend our long track record of consistently delivering strong adjusted EPS growth,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We leveraged our solid top-line results and our culture of operational discipline to achieve excellent performance on the bottom line. I’m also pleased to report that […]
Waters Corporation (NYSE:WAT) reported today third quarter 2014 sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (EPS) for the third quarter were $1.34 compared to $1.14 for the third […]
Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Since then, the business has not met growth and profitability objectives. Agilent will stop taking new NMR system orders immediately, but the company will continue to meet customer commitments for orders in progress […]
BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing NGS to genotyping for agricultural applications. For further details […]